Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
NVS [NYSE]
Novartis AG
Index- P/E22.88 EPS (ttm)3.70 Insider Own- Shs Outstand2.72B Perf Week1.00%
Market Cap230.55B Forward P/E15.18 EPS next Y5.58 Insider Trans- Shs Float433.53M Perf Month4.26%
Income9.18B PEG4.32 EPS next Q1.35 Inst Own10.00% Short Float0.73% Perf Quarter7.03%
Sales58.83B P/S3.92 EPS this Y-2.40% Inst Trans0.01% Short Ratio1.67 Perf Half Y18.30%
Book/sh30.57 P/B2.77 EPS next Y5.36% ROA7.40% Target Price84.34 Perf Year21.53%
Cash/sh3.34 P/C25.35 EPS next 5Y5.30% ROE13.00% 52W Range65.46 - 85.23 Perf YTD8.89%
Dividend2.72 P/FCF- EPS past 5Y0.80% ROI10.20% 52W High-0.66% Beta0.58
Dividend %3.21% Quick Ratio0.90 Sales past 5Y6.70% Gross Margin66.70% 52W Low29.34% ATR1.09
Employees135696 Current Ratio1.20 Sales Q/Q2.00% Oper. Margin19.40% RSI (14)61.37 Volatility1.07% 1.05%
OptionableYes Debt/Eq0.24 EPS Q/Q1.20% Profit Margin15.60% Rel Volume0.51 Prev Close84.41
ShortableYes LT Debt/Eq0.15 EarningsApr 19 Payout64.70% Avg Volume1.89M Price84.67
Recom2.30 SMA202.09% SMA503.67% SMA20011.63% Volume963,745 Change0.31%
16-Nov-09Initiated Deutsche Securities Buy
12-Nov-09Initiated Barclays Capital Underweight $48
30-Sep-09Upgrade Citigroup Hold → Buy
15-Sep-09Upgrade Jefferies & Co Hold → Buy
17-Jul-09Upgrade JP Morgan Neutral → Overweight
17-Mar-09Initiated Credit Suisse Neutral
27-Feb-09Reiterated Credit Suisse Neutral $14 → $7
26-Jan-09Initiated Jefferies & Co Hold
23-Sep-08Upgrade Credit Suisse Underperform → Neutral
06-Aug-08Downgrade JP Morgan Overweight → Neutral
12-Jun-08Downgrade HSBC Securities Neutral → Underweight $52 → $49
04-Jun-08Upgrade Cowen & Co Neutral → Outperform
09-May-08Upgrade Bernstein Mkt Perform → Outperform
08-Apr-08Downgrade Bear Stearns Outperform → Peer Perform
29-Feb-08Initiated Cowen & Co Neutral
29-Feb-08Downgrade HSBC Securities Neutral → Underweight
06-Sep-07Initiated UBS Buy
18-Jul-07Downgrade Credit Suisse Neutral → Underperform
01-Jun-07Reiterated Prudential Overweight $64 → $62
02-Apr-07Reiterated Banc of America Sec Buy $66 → $65
17-Apr-14 04:44PM  The Law of Gravity Isn't Working for This Off-Patent Drug at BusinessWeek
03:00PM  Roche Meets Sales Estimates in Q1 Zacks
16-Apr-14 03:23PM  As big pharma backs away, Alnylam sees deja vu at CNBC
02:28PM  Will Recent News Hurt GlaxoSmithKline? at Wall St. Cheat Sheet
01:51PM  Alnylam COO critical of big pharma, FierceDrugDelivery reports theflyonthewall.com
08:25AM  Does Johnson & Johnson Belong in Your Portfolio? at Wall St. Cheat Sheet
15-Apr-14 02:32PM  Does Pfizer Offer Good Value? at Motley Fool
09:07AM  Ranbaxys Woes Add $900 Million to U.S. Heart Drug Costs at Bloomberg
09:04AM  Big Pharma's Turn On RNAi Shows That New Technologies Don't Guarantee R&D Success at Forbes
14-Apr-14 08:24PM  Ranbaxys Woes Add $900 Million to U.S. Heart Drug Costs Bloomberg
02:42PM  Alnylam slips after Novartis reportedly cuts back RNAi development at theflyonthewall.com
12:11PM  Novartis Wins Court Order Blocking U.K. Animal-Rights Protests at Bloomberg
11:17AM  Novartis to Shire Said to Weigh Bids for ThromboGenics at Bloomberg
11-Apr-14 03:07PM  FDA Approves Novartis' ALK Inhibitor! Maybe...Really Soon? at TheStreet
02:32PM  Can This Drug Be a Game Changer for Eli Lilly? at Motley Fool
10-Apr-14 02:44PM  [video] Hot dividend picks at CNBC
11:51AM  French probe alleged drug collusion at Financial Times
11:43AM  [video] Pfizer CEO worries about ACA coverage at CNBC
10:46AM  Europe shares lower; BoE holds interest rate at 0.5% at CNBC
10:10AM  [$$] French Authorities Raid Local Offices of Roche, Novartis at The Wall Street Journal
10:02AM  Europe shares mixed; BoE holds interest rate at 0.5% at CNBC
09:33AM  Europe shares higher; BoE holds interest rate at 0.5% at CNBC
09:31AM  3 Breast Cancer Drugs With Big Potential at Motley Fool
09:03AM  Europe shares higher; BoE holds interest rate at 0.5% at CNBC
07:55AM  Europe shares higher; BoE holds interest rate at 0.5% at CNBC
03:00AM  Europe opens higher on dovish Fed; BoE decision ahead at CNBC
09-Apr-14 08:40AM  Tale Of Two Heart Drugs Show Challenges And Rewards In R&D at Forbes
08:03AM  [$$] Novartis Names New Division Heads at The Wall Street Journal
08-Apr-14 11:56AM  Cancer-Fighter Juno Therapeutics Hits The Pause Button On Trial After Patient Deaths at Forbes
11:56AM  Cancer-Fighter Juno Therapeutics Hits The Pause Button After Patient Deaths at Forbes
09:40AM  Encouraging Results from Pfizer's Palbociclib Zacks
07-Apr-14 06:05PM  Mallinckrodt, Questcor Merger Gets Mixed Reception at Investor's Business Daily
02:45PM  Why Pfizer (PFE) Stock Is Down On Monday at TheStreet
12:46PM  FDA Grants Breakthrough Therapy Designation To Novartis' Meningitis B Vaccine at Forbes
12:46PM  FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B at Forbes
12:13PM  FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B at Forbes
10:40AM  Good News for Novartis' Bexsero Zacks
09:31AM  Novartis AG Seeks to Pump More Value into its R&D at Motley Fool
09:19AM  Todays Top Biotech Stories: MannKind, Mallinckrodt, Questcor, and Novartis at Motley Fool
08:33AM  Mallinckrodt to Buy Questcor for $5.6 Billion at New York Times
08:33AM  Mallinckrodt to Buy Californias Questcor for $5.6 Billion at New York Times
08:33AM  Mallinckrodt Pharmaceuticals to Buy Questcor for $5.6 Billion at New York Times
08:33AM  Drug Maker Mallinckrodt to Buy Questcor of California for $5.6 Billion at New York Times
01:39AM  Novartis' meningitis B vaccine wins breakthrough therapy status in U.S. Reuters
06-Apr-14 10:39AM  Pfizer Breast Cancer Drug Results "As Impressive As I've Ever Seen," Researcher Says at Forbes
04-Apr-14 12:38AM  [$$] Novartis Replaces Top Management in Japan at The Wall Street Journal
12:29AM  [$$] Novartis Replaces Top Management in Japan at The Wall Street Journal
03-Apr-14 11:50PM  [$$] Novartis Replaces Top Management in Japan at The Wall Street Journal
08:33PM  [$$] White House Calls Samsung Out at The Wall Street Journal
08:19PM  [$$] Discounts Are Piled On for Basics at The Wall Street Journal
07:41PM  [$$] Microsoft Frames Itself as Underdog at The Wall Street Journal
06:55PM  [$$] The Culture of General Motors at The Wall Street Journal
06:35PM  [$$] Pentagon Sets Up Rocket Race at The Wall Street Journal
05:57PM  David Letterman Announces Retirement at The Wall Street Journal
05:12PM  [$$] AIG Sues State Financial Regulator in Licensing Dispute at The Wall Street Journal
04:28PM  [$$] Micron Technology Swings to Profit at The Wall Street Journal
04:06PM  [$$] Globalfoundries Emerges as Lead Candidate to Buy IBM Chip Plants at The Wall Street Journal
03:32PM  [$$] Ford Outpaces Bigger Rivals in China at The Wall Street Journal
10:33AM  Will Pfizer Unveil A Breast Cancer Blockbuster This Sunday? at Forbes
08:06AM  Apricus Biosciences granted national phase approval for Vitaros in Luxembourg at theflyonthewall.com
07:12AM  [$$] BAIC Seeks Foreign Brands at The Wall Street Journal
06:26AM  [$$] BAIC Seeks Foreign Acquisition Targets at The Wall Street Journal
06:03AM  [$$] Vodafone to Create 1,400 Jobs at The Wall Street Journal
05:28AM  [$$] Novartis Shakes Up Japan Ranks at The Wall Street Journal
04:48AM  Novartis Replaces Japan Unit Head Ninomiya Amid Drug Test Probe at Bloomberg
02-Apr-14 02:31PM  Biggest Clinical Wins of the Week: Large-Cap Edition at Motley Fool
02:21PM  [$$] Senators Challenge GM Chief on Culture at The Wall Street Journal
01:33PM  Amazon Unveils Video-Streaming Device Fire TV at The Wall Street Journal
01:08PM  Amazon Unveils Video-Streaming Device Fire TV at The Wall Street Journal
12:33PM  Amazon Unveils Video-Streaming Device Fire TV at The Wall Street Journal
11:58AM  What You Need to Know About the GM Recalls at The Wall Street Journal
11:26AM  [$$] Amazon Unveils Video-Streaming Device at The Wall Street Journal
10:42AM  [$$] GM CEO: Executives to Have Bigger Recall Role at The Wall Street Journal
10:15AM  [$$] Widow of Insurance Company's Late CFO Speaks to Shareholders at The Wall Street Journal
09:30AM  [$$] Germany Fines More Breweries at The Wall Street Journal
09:04AM  [$$] Investors Warm to Green Bonds at The Wall Street Journal
09:01AM  Whats Next for MannKind Corp.? at Motley Fool
06:34AM  Novartis price target raised to $93 from $88 at Leerink theflyonthewall.com
01-Apr-14 08:41PM  Here's Why Celgene Boosted Its Bet on Forma Therapeutics at Motley Fool
06:32PM  What You Need to Know About High Blood Pressure Drugs at Motley Fool
03:30PM  Positive News for Novartis' LCZ696 Zacks
10:30AM  Novartis' Lead Ceritinib Could Capture Market Share From Pfizer at Seeking Alpha
31-Mar-14 06:10PM  Setback for Novartis Zacks
04:26PM  On The Fly: Closing Wrap at theflyonthewall.com
03:58PM  Is Johnson & Johnson an Attractive Investment? at Wall St. Cheat Sheet
03:20PM  Todays Top Biotech Stories: Curis, Amgen, and Novartis at Motley Fool
03:20PM  This Week in Biotech: Biogen Idec Gets a Key Approval While Insmed Confuses Investors at Motley Fool
02:55PM  Novartis Trial Was Stopped Early Because Of A Significant Drop In Cardiovascular Mortality at Forbes
02:47PM  Why Novartis (NVS) Stock Is Higher Today at TheStreet
01:41PM  Novartis rises after committee recommends early closure of study at theflyonthewall.com
11:51AM  GM down on latest report; Panera rising on an upgrade; Novartis pops on positive drug news Breakout
11:51AM  GM down on latest report; Panera rising on an upgrade, Novartis pops on positive drug news Breakout
11:38AM  Teva advances after Supreme Court agrees to hear Copaxone appeal at theflyonthewall.com
10:23AM  Undervalued Swiss Companies with a Catalyst Kicker: A Wall Street Transcript Interview with Philippe Comby, Vice President and Chief Financial Officer of the Swiss Helvetia Fund Inc. Wall Street Transcript
10:06AM  Effectiveness prompts Novartis to end drug study AP
09:38AM  Early Success For Novel Novartis Heart Failure Drug at Forbes
09:00AM  Stock Futures Look Favorable; Legg Mason, Novartis, Climb at Investor's Business Daily
08:49AM  [$$] BP Russia Names New Head at The Wall Street Journal
07:48AM  Early movers: LULU, GM, TSLA, C, AAPL, BBRY & more at CNBC
01:55AM  Novartis Says Final-Phase Study on Heart Drug Was Successful at Bloomberg
Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, including oncology; primary care and established medicines; specialty care, such as ophthalmology, neuroscience, integrated hospital care, and critical care; and cardiovascular and metabolism. The company's Alcon division provides various eye care products, including ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses; medicines to treat chronic and acute diseases of the eye; over-the-counter medicines for the eye; and contact lenses and lens care products. Its Sandoz division offers prescription medicines, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; active pharmaceutical ingredients and intermediates, primarily antibiotics; protein or biotechnology-based products; cytotoxic products for the hospital market; and biotech manufacturing services to other companies. The company's Vaccines and Diagnostics division provides preventive human vaccines. Its Consumer Health division offers over-the-counter medicines comprising readily available consumer medicines; and Animal Health, which provides veterinary products for farm and companion animals. The company distributes its OTC products through various channels, such as food, drug, and mass retail outlets, as well as pharmacies; and Animal Health products directly and through wholesalers of veterinary products. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.